ArticleActa pharmaceutica Sinica. B2020

Discovery of highly selective and orally available benzimidazole-based phosphodiesterase 10 inhibitors with improved solubility and pharmacokinetic properties for treatment of pulmonary arterial hypertension.

Yuncong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.